COVID-19-assoziierte Krankheitsverläufe verbunden; dies unterstreicht, wie wichtig es ist, dass Erwachsene die empfohlenen COVID-19-Impfungen erhalten.«
jamanetwork.com/journals/jam...
This case-control study assesses the effectiveness of the COVID-19 vaccine formulation for 2024 to 2025 against medically attended COVID-19 among adults 18 years and older in the US.